"Sarcoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant.
| Descriptor ID |
D012509
|
| MeSH Number(s) |
C04.557.450.795
|
| Concept/Terms |
Sarcoma- Sarcoma
- Sarcomas
- Sarcoma, Soft Tissue
- Sarcomas, Soft Tissue
- Soft Tissue Sarcoma
- Soft Tissue Sarcomas
Sarcoma, Epithelioid- Sarcoma, Epithelioid
- Epithelioid Sarcoma
- Epithelioid Sarcomas
- Sarcomas, Epithelioid
Sarcoma, Spindle Cell- Sarcoma, Spindle Cell
- Sarcomas, Spindle Cell
- Spindle Cell Sarcoma
- Spindle Cell Sarcomas
|
Below are MeSH descriptors whose meaning is more general than "Sarcoma".
Below are MeSH descriptors whose meaning is more specific than "Sarcoma".
This graph shows the total number of publications written about "Sarcoma" by people in this website by year, and whether "Sarcoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 2004 | 0 | 2 | 2 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 2 | 0 | 2 |
| 2014 | 1 | 0 | 1 |
| 2015 | 2 | 1 | 3 |
| 2016 | 1 | 0 | 1 |
| 2019 | 3 | 0 | 3 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sarcoma" by people in Profiles.
-
In Reply to the Letter to the Editor Regarding "Genetically Distinct Oligosarcoma Arising from Oligodendroglioma: Systematic Review & Illustrative Case Example". World Neurosurg. 2024 Sep; 189:553.
-
GLI1 Immunohistochemistry Distinguishes Mesenchymal Neoplasms With GLI1 Alterations From Morphologic Mimics. Am J Surg Pathol. 2023 04 01; 47(4):453-460.
-
Survival analyses of soft tissue pleomorphic sarcomas and a proposed leiomyosarcoma-specific dynamic nomogram: A large population-based study. Pathol Res Pract. 2022 Sep; 237:153999.
-
A Phase Ib/II Randomized Study of RO4929097, a Gamma-Secretase or Notch Inhibitor with or without Vismodegib, a Hedgehog Inhibitor, in Advanced Sarcoma. Clin Cancer Res. 2022 04 14; 28(8):1586-1594.
-
NUTM1-Rearranged Neoplasms-A Heterogeneous Group of Primitive Tumors with Expanding Spectrum of Histology and Molecular Alterations-An Updated Review. Curr Oncol. 2021 11 07; 28(6):4485-4503.
-
Clinical Activity of Single-Agent Cabozantinib (XL184), a Multi-receptor Tyrosine Kinase Inhibitor, in Patients with Refractory Soft-Tissue Sarcomas. Clin Cancer Res. 2022 01 15; 28(2):279-288.
-
Advances in the Diagnosis and Management of Neonatal Sarcomas. Clin Perinatol. 2021 03; 48(1):117-145.
-
EWSR1-PATZ1-rearranged sarcoma: a report of nine cases of spindle and round cell neoplasms with predilection for thoracoabdominal soft tissues and frequent expression of neural and skeletal muscle markers. Mod Pathol. 2021 04; 34(4):770-785.
-
Capicua Transcriptional Repressor-Rearranged Undifferentiated Round Cell Sarcoma Metastatic to the Brain Treated with Surgery and Stereotactic Radiosurgery. World Neurosurg. 2020 07; 139:12-19.
-
Infantile Epithelioid Sarcoma with Genomic Segmental Amplification of BIRC3/YAP1 as Double Minutes Plus Trisomy 2: A Case Report. Fetal Pediatr Pathol. 2020 Feb; 39(1):51-61.